eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of…
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of eFFECTOR Therapeutics, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | FMP | High | United States | Redwood City | |
| Ensysce Biosciences, Inc. | FMP | High | United States | La Jolla | |
| Indaptus Therapeutics, Inc. | FMP | High | United States | New York | |
| RenovoRx, Inc. | FMP | High | United States | Los Altos | |
| Virpax Pharmaceuticals, Inc. | FMP | High | United States | Berwyn |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |